The place of targeted therapies in the management of non-small cell bronchial carcinoma-Reference-Cited by-同舟云学术

The place of targeted therapies in the management of non-small cell bronchial carcinoma

Published:2006-11 Issue:5 Volume:23 Page:131-136
ISSN:0761-8425
Container-title:Revue des Maladies Respiratoires
language:fr
Short-container-title:Revue des Maladies Respiratoires

Author:

Rosell R.,Moran T.,Fernanda Salazar M.,Mendez P.,De Aguirre I.,Ramirez J.-L.,Isla D.,Cobo M.,Camps C.,Lopez-Vivanco G.,Alberola V.,Taron M.

Publisher

Elsevier BV

Subject

Pulmonary and Respiratory Medicine

Reference36 articles.

1. Clinical model to predict survival in chemonaive patients with advanced non-small-cell lung cancer treated with third-generation chemotherapy regimens based on Eastern Cooperative Oncology Group data;Hoang;J Clin Oncol,2005

2. Messenger RNA levels of XPAC and ERCC1 in ovarian cancer tissue correlate with response to platinum-based chemotherapy;Dabholkar;J Clin Invest,1994

3. Low ERCC1 expression correlates with prolonged survival after cisplatin plus gemcitabine chemotherapy in non-small-cell lung cancer;Lord;Clin Cancer Res,2002

4. ERCC1 m RNA-based randomized phase III trial of docetaxel doublets with cisplatin or gemcitabine in stage IV non-small-cell lung cancer patients;Cobo;Lung Cancer,2005

5. BRCA1 up-regulation is associated with repair-mediated resistance to cis-diamminedichloroplatinum (II);Husain;Cancer Res,1998

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The lncRNA ALMS1‐IT1 may promote malignant progression of lung adenocarcinoma via AVL9‐mediated activation of the cyclin‐dependent kinase pathway;FEBS Open Bio;2021-04-03

2. Emodin affects ERCC1 expression in breast cancer cells;Journal of Translational Medicine;2012-09

3. Sumoylation of eukaryotic elongation factor 2 is vital for protein stability and anti-apoptotic activity in lung adenocarcinoma cells;Cancer Science;2011-06-23

4. ATPase family AAA domain-containing 3A is a novel anti-apoptotic factor in lung adenocarcinoma cells;Journal of Cell Science;2010-04-01

5. Expression of short-form oncostatin M receptor as a decoy receptor in lung adenocarcinomas;The Journal of Pathology;2008-07